These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6261429)

  • 1. Attempts to obtain monoclonal antibody against MMTV tumors.
    Tax A; Manson LA
    Transplant Proc; 1980 Sep; 12(3):391-3. PubMed ID: 6261429
    [No Abstract]   [Full Text] [Related]  

  • 2. Autogenous immunity to mouse mammary tumor virus in mouse strains of high and low mammary tumor incidence.
    Ihle JN; Arthur LO; Fine DL
    Cancer Res; 1976 Aug; 36(8):2840-4. PubMed ID: 179709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immunity to mammary tumor virus in normal and tumor-bearing C3H/HeN mice.
    Tagliabue A; Herberman RB; McCoy JL
    Cancer Res; 1978 Aug; 38(8):2279-84. PubMed ID: 208765
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantitation of viral antigens released into plasma and culture fluids by murine mammary tumor cells.
    Ritzi EM; Smith BA; Stolfi RL; Martin DS
    Cancer Res; 1981 Oct; 41(10):3885-90. PubMed ID: 6269731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoelectron microscopic studies of antibodies in mouse sera directed against mouse mammary tumor virus.
    Miller MF; Dmochowski L; Bowen JM
    Cancer Res; 1977 Jul; 37(7 Pt 1):2086-91. PubMed ID: 193633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody in the sera of tumor-bearing mice that mediates spleen cell cytotoxicity toward the autologous tumor.
    Blair PB; Lane MA; Mar P
    J Immunol; 1976 Mar; 116(3):606-9. PubMed ID: 176266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complexity of factors in sera of different mice that affect MTV-induced mammary tumor cells.
    Blair PB; Lane MA; Mar P
    J Immunol; 1976 Mar; 116(3):610-4. PubMed ID: 176267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B and T cells are required for mouse mammary tumor virus spread within the mammary gland.
    Golovkina TV; Dudley JP; Ross SR
    J Immunol; 1998 Sep; 161(5):2375-82. PubMed ID: 9725233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An antigen cross-reactive with gp52 of mammary tumor virus is expressed on a B cell subpopulation of mice.
    Tax A; Ewert D; Manson LA
    J Immunol; 1983 May; 130(5):2368-71. PubMed ID: 6300244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse mammary tumor virus associated antigens and superantigens--immuno-molecular correlates of neoplastic progression.
    Wei WZ; Gill RF; Wang H
    Semin Cancer Biol; 1993 Jun; 4(3):205-13. PubMed ID: 8391342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced immune reactivity to hepatoma 22a cells in MTV-infected compared with MTV-free C3H mice.
    Lavrovsky VA; Viksler VK
    Immunology; 1981 Dec; 44(4):671-6. PubMed ID: 6274791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody-recognizing tumor-associated antigen of DBA/2 mouse lymphoma L1210 and its sublines.
    Fuji H
    Transplant Proc; 1980 Sep; 12(3):388-90. PubMed ID: 6784299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies to human tumor antigens.
    Steplewski Z
    Transplant Proc; 1980 Sep; 12(3):384-7. PubMed ID: 7222217
    [No Abstract]   [Full Text] [Related]  

  • 15. Murine mammary tumor virus seroepidemiology in BALB/cfC3H mice: correlation with tumor development.
    Altrock BW; Cardiff RD; Blair PB
    J Natl Cancer Inst; 1981 Jul; 67(1):163-8. PubMed ID: 6265680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro detection of immune responses to MTV-induced mammary tumors: activity of spleen cell preparations from both MTV-free and MTV-infected mice.
    Blair PB; Lane MA; Yagi MJ
    J Immunol; 1974 Feb; 112(2):693-705. PubMed ID: 4360546
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of H-2 histocompatibility on generation of cell-mediated cytotoxicity against virus-induced mammary tumors in C3H mice.
    Stutman O
    Transplant Proc; 1977 Mar; 9(1):1153-5. PubMed ID: 194369
    [No Abstract]   [Full Text] [Related]  

  • 18. Naturally occurring humoral immunity to murine mammary tumor virus (MuMTV) and MuMTV GP52 in mice with low mammary tumor incidence.
    Arthur LO; Fine DL
    Int J Cancer; 1978 Dec; 22(6):734-40. PubMed ID: 214408
    [No Abstract]   [Full Text] [Related]  

  • 19. The biochemical and biological characterization of lymphocyte regulatory molecules. VI. Generation of a B cell hybridoma whose antibody product inhibits interleukin 2 activity.
    Gillis S; Henney CS
    J Immunol; 1981 May; 126(5):1978-84. PubMed ID: 6971316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
    Hodes RJ; Novick MB; Palmer LD; Knepper JE
    J Immunol; 1993 Feb; 150(4):1422-8. PubMed ID: 8094408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.